Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis
Journal article
Tse, G. 2023. Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis. Diabetes Epidemiology and Management. 9, p. 100115. https://doi.org/10.1016/j.deman.2022.100115
Authors | Tse, G. |
---|---|
Abstract | Background Methods Results Conclusions |
Keywords | Pancreatitis; Pancreatic cancer; Sodium glucose cotransporter 2 (SGLT2) inhibitors; Dipeptidyl peptidase-4 (DPP4) inhibitors |
Year | 2023 |
Journal | Diabetes Epidemiology and Management |
Journal citation | 9, p. 100115 |
Publisher | Elsevier |
ISSN | 2666-9706 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.deman.2022.100115 |
Official URL | https://www.sciencedirect.com/science/article/pii/S2666970622000658 |
Publication dates | |
Online | 23 Nov 2022 |
Publication process dates | |
Accepted | 27 Oct 2022 |
Deposited | 19 May 2023 |
Publisher's version | License |
Output status | Published |
https://repository.canterbury.ac.uk/item/949q3/lower-risks-of-new-onset-acute-pancreatitis-and-pancreatic-cancer-in-sodium-glucose-cotransporter-2-sglt2-inhibitors-compared-to-dipeptidyl-peptidase-4-dpp4-inhibitors-a-propensity-score-matched
Download files
58
total views40
total downloads1
views this month0
downloads this month